Literature DB >> 18407604

Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein.

Yan-Ming Zhou1, Jia-Mei Yang, Bin Li, Zheng-Feng Yin, Feng Xu, Bin Wang, Peng Liu, Zhi-Min Li.   

Abstract

AIM: To explore clinicopathologic characteristics of intrahepatic cholangiocarcinoma (ICC) in patients with positive serum a-fetoprotein (AFP).
METHODS: One hundred and thirty one patients who underwent surgical dissection for pathologically confirmed ICC were divided into a positive AFP (> 20 ng/mL) group (n = 32) and a negative AFP group (n = 99), whose clinicopathologic features were analyzed and compared.
RESULTS: The positive rate of HBsAg and liver cirrhosis of the positive AFP group was higher than that of the negative AFP group, while the positive rate of CA19-9 (> 37 U/mL) and the lymph node metastasis rate was lower.
CONCLUSION: ICC patients with positive AFP share many clinicopathologic similarities with hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18407604      PMCID: PMC2703855          DOI: 10.3748/wjg.14.2251

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

Review 1.  Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment.

Authors:  M F Chen
Journal:  J Gastroenterol Hepatol       Date:  1999-12       Impact factor: 4.029

2.  Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma.

Authors:  D M Parkin; P Srivatanakul; M Khlat; D Chenvidhya; P Chotiwan; S Insiripong; K A L'Abbé; C P Wild
Journal:  Int J Cancer       Date:  1991-05-30       Impact factor: 7.396

3.  Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea.

Authors:  H R Shin; C U Lee; H J Park; S Y Seol; J M Chung; H C Choi; Y O Ahn; T Shigemastu
Journal:  Int J Epidemiol       Date:  1996-10       Impact factor: 7.196

4.  Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma.

Authors:  T Isa; T Kusano; H Shimoji; Y Takeshima; Y Muto; M Furukawa
Journal:  Am J Surg       Date:  2001-06       Impact factor: 2.565

5.  Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.

Authors:  Annika Bergquist; Anders Ekbom; Rolf Olsson; Dan Kornfeldt; Lars Lööf; Ake Danielsson; Rolf Hultcrantz; Stefan Lindgren; Hanne Prytz; Hanna Sandberg-Gertzén; Sven Almer; Fredrik Granath; Ulrika Broomé
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

6.  Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.

Authors:  U Broomé; R Löfberg; B Veress; L S Eriksson
Journal:  Hepatology       Date:  1995-11       Impact factor: 17.425

7.  Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.

Authors:  Peiguo G Chu; Shin Ishizawa; Emerald Wu; Lawrence M Weiss
Journal:  Am J Surg Pathol       Date:  2002-08       Impact factor: 6.394

8.  Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China.

Authors:  Yan-Ming Zhou; Zheng-Feng Yin; Jia-Mei Yang; Bin Li; Wen-Yu Shao; Feng Xu; Yu-Lan Wang; Dian-Qi Li
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

9.  Hepatic progenitor cells in human liver cirrhosis: immunohistochemical, electron microscopic and immunofluorencence confocal microscopic findings.

Authors:  Jia-Cheng Xiao; Xiao-Long Jin; Peter Ruck; Anne Adam; Edwin Kaiserling
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

10.  Elevation of serum alpha-fetoprotein and proliferation of oval cells in the livers of LEC rats.

Authors:  H Takahashi; M Oyamada; Y Fujimoto; M I Satoh; A Hattori; K Dempo; M Mori; T Tanaka; H Watabe; R Masuda
Journal:  Jpn J Cancer Res       Date:  1988-07
View more
  9 in total

1.  Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.

Authors:  Xin Zhang; Wen-Juan Huang; Meng-Lin Zhang; Wen Wang; Ye Niu; Rui-Tao Wang; Zeng-Yao Liu
Journal:  BMC Gastroenterol       Date:  2022-06-06       Impact factor: 2.847

Review 2.  Hepatitis B virus infection and intrahepatic cholangiocarcinoma.

Authors:  Hua-Bang Zhou; Jing-Yi Hu; He-Ping Hu
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 3.  HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis.

Authors:  Hao Zhang; Biqing Zhu; He Zhang; Jianxin Liang; Wenting Zeng
Journal:  Biomed Res Int       Date:  2016-11-23       Impact factor: 3.411

4.  Alpha-Fetoprotein as a Predictive Marker for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure.

Authors:  Xiaoping Wang; Caifei Shen; Jianjiang Yang; Xianjun Yang; Sen Qin; Haijun Zeng; Xiaoling Wu; Shanhong Tang; Weizheng Zeng
Journal:  Can J Gastroenterol Hepatol       Date:  2018-05-09

5.  A Novel Prognostic Scoring System of Intrahepatic Cholangiocarcinoma With Machine Learning Basing on Real-World Data.

Authors:  Zhizhen Li; Lei Yuan; Chen Zhang; Jiaxing Sun; Zeyuan Wang; Yu Wang; Xin Hao; Fei Gao; Xiaoqing Jiang
Journal:  Front Oncol       Date:  2021-01-20       Impact factor: 6.244

6.  Hepatitis B virus precore/core region mutations and genotypes among hepatitis B virus chronic carriers in South-Eastern, Nigeria.

Authors:  Chinenye Mbamalu; Ifeoma Ekejindu; Ifeoma Enweani; Stephen Kalu; David Igwe; Gloria Akaeze
Journal:  Int J Health Sci (Qassim)       Date:  2021 Mar-Apr

Review 7.  Assessment of liver cancer biomarkers.

Authors:  Vahid Mansouri; Mohhamadreza Razzaghi; Abdolrahim Nikzamir; Alireza Ahmadzadeh; Majid Iranshahi; Mehrdad Haghazali; Mostafa Hamdieh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2020

Review 8.  Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A case report and review of the literature.

Authors:  Meng-Meng Qu; Yuan-Hui Zhu; Yi-Xiang Li; Zhi-Fan Li; Jin-Kui Li; Yong-Sheng Xu; Manishkumar Shrestha; Jun-Qiang Lei
Journal:  Medicine (Baltimore)       Date:  2021-11-19       Impact factor: 1.889

9.  Double-Negative α-Fetoprotein and Carbohydrate Antigen 19-9 Predict a Good Prognosis in Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis.

Authors:  Xiaoyun Zhang; Yongjie Zhou; Zhenru Wu; Wei Peng; Chuan Li; Lvnan Yan; Jiayin Yang; Tianfu Wen
Journal:  Clin Transl Gastroenterol       Date:  2021-11-09       Impact factor: 4.488

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.